Wärnberg, F.; Karlsson, P.; Holmberg, E.; Sandelin, K.; Whitworth, P.W.; Savala, J.; Barry, T.; Leesman, G.; Linke, S.P.; Shivers, S.C.;
et al. Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers 2021, 13, 6103.
https://doi.org/10.3390/cancers13236103
AMA Style
Wärnberg F, Karlsson P, Holmberg E, Sandelin K, Whitworth PW, Savala J, Barry T, Leesman G, Linke SP, Shivers SC,
et al. Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers. 2021; 13(23):6103.
https://doi.org/10.3390/cancers13236103
Chicago/Turabian Style
Wärnberg, Fredrik, Per Karlsson, Erik Holmberg, Kerstin Sandelin, Pat W. Whitworth, Jess Savala, Todd Barry, Glen Leesman, Steven P. Linke, Steven C. Shivers,
and et al. 2021. "Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)" Cancers 13, no. 23: 6103.
https://doi.org/10.3390/cancers13236103
APA Style
Wärnberg, F., Karlsson, P., Holmberg, E., Sandelin, K., Whitworth, P. W., Savala, J., Barry, T., Leesman, G., Linke, S. P., Shivers, S. C., Vicini, F., Shah, C., Weinmann, S., Mann, G. B., & Bremer, T.
(2021). Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers, 13(23), 6103.
https://doi.org/10.3390/cancers13236103
